Penetration fractions of photons from the cell-medium system for photons with incident energies of (a) 10 keV, (b) 100 keV and (c) 1 MeV. by Mehrdad Shahmohammadi Beni (796228)

Scatter plot for the absolute decrease in CS rates (A) and the relative decrease in CS rates (B) from 2008 to 2016 among hospitals in Guangzhou grouped by their baseline CS rates. by Xiaoyan Xia (560153)

“…<p>A total of 112 hospitals with more than 100 live births both at baseline and in Stage 2 were included and were grouped by their baseline CS rates. …”

Gliocentric shift due to S100B and APP/Aβ42 in DS HNPs. by Jie Lu (139953)

“…Co-treatment with S100B and Aβ42 for 24 hours leads to an additive increase in GFAP and decrease in MAP2 expression levels. …”

HvPIN1a localisation is influenced by BFA and its expression is decreased by cytokinin. by Gwendolyn K. Kirschner (5142644)

β-catenin shRNA alters the expression of EMT-related markers in PDAC cells in vitro. by Xue Chen (127892)

Overview of clot-fibrinolysis waveform analysis point of time and parameters. by Tomoko Matsumoto (12237335)

DGAT-1 Inhibitor A922500 decreases the pro-inflammatory profile and cell death induced by SARS-CoV-2 infection and reduces the viral load in human monocyte. by Suelen Silva Gomes Dias (9928813)

PRISMA flow diagram for the literature search. by Heloisa Ricci Conesa (18291210)

Subjects:

Data extraction grid. by Heloisa Ricci Conesa (18291210)

Subjects:

Introduction status of PCVs in European countries over time. by Heloisa Ricci Conesa (18291210)

Subjects:

Serotype-specific penicillin non-susceptibility during different PCV periods in Iceland, Romania, Spain and Belgium [68, 69, 76, 78, 84, 85]. by Heloisa Ricci Conesa (18291210)

Subjects:

Serotype distributions over time for reported "non-PCV" serotypes. by Heloisa Ricci Conesa (18291210)

Subjects:

Incidence rates of AOM cases. by Heloisa Ricci Conesa (18291210)

Subjects:

Inclusion criteria. by Heloisa Ricci Conesa (18291210)

Subjects:

Frequency (%) of PCV-serotypes identified between 2011–2021 by testing source and country. by Heloisa Ricci Conesa (18291210)

Subjects:

Penicillin non-susceptibility¹ of S. pneumoniae over time, by country and sample size [11, 12, 60, 66, 68–73, 75–77, 79–86]. by Heloisa Ricci Conesa (18291210)

Subjects:

The number of studies with data for each of the included countries. by Heloisa Ricci Conesa (18291210)

Subjects:

Time trends of changes in AOM hospitalization incidence rates. by Heloisa Ricci Conesa (18291210)

Subjects:

Number of papers included by year and outcome category. by Heloisa Ricci Conesa (18291210)

Subjects:

Effects of vesicle radius and steady state <i>p</i>H on H⁺ and <i>p</i>H fluctuations as predicted from our DS model. by Apeksha Singh (8174256)